Four separate securities class-action notices concern Hims & Hers Health, Inc., Innventure, Inc., Hyliion Holdings Corp. and HDFC Bank Limited, with no indication that they arise from one underlying event. The Hims & Hers notice cites a November 2, 2026 lead-plaintiff deadline and allegations involving undisclosed sharing of consumers' health information, near-immediate prescription charges and regulatory exposure. The Innventure and Hyliion notices each set an October 27, 2026 deadline. Innventure investors covered by the November 17, 2025 through August 13, 2026 period are accused of receiving misleading information about Accelsius' proposed DarkNX transaction and 2026 revenue and cash-flow targets, while Hyliion investors covered by May 12 through June 23, 2026 face allegations involving the credibility of its commercial pipeline and VFG Holdings partnership. The HDFC notice sets an October 13, 2026 deadline for investors who purchased HDFC securities from July 17, 2023 through May 26, 2026, alleging that the bank disguised roughly Rs 45 crore as marketing expenditures to pay above-market interest on deposits from the Maharashtra State Road Development Corporation. HDFC shares fell $1.02, or 4.1%, on May 27, 2026, after the allegations were reported. The notices state that investors may retain counsel of their choice, seek lead-plaintiff status or remain absent class members without taking action.